Fanconi syndrome-ichthyosis-dysmorphism syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1981
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fanconi syndrome-ichthyosis-dysmorphism syndrome, also known as Fanconi renotubular syndrome with ichthyosis and dysmorphism or sometimes referred to as Fanconi ichthyosis dysmorphism (FID) syndrome, is an extremely rare multisystem disorder characterized by the combination of renal Fanconi syndrome (a dysfunction of the proximal renal tubules), congenital ichthyosis (a skin disorder with widespread scaling), and distinctive facial dysmorphic features. The condition is present from birth and primarily affects the kidneys, skin, and craniofacial structures. The renal Fanconi syndrome component leads to excessive loss of amino acids, glucose, phosphate, bicarbonate, and other substances in the urine due to impaired proximal tubular reabsorption. This can result in metabolic acidosis, rickets, failure to thrive, and electrolyte imbalances. The ichthyosis manifests as generalized dry, scaly skin that may be present at birth or develop shortly thereafter. Dysmorphic features may include a flattened nasal bridge, micrognathia, and other craniofacial anomalies. Additional features reported in some patients include growth retardation and developmental delay. Given the extreme rarity of this condition, with only a handful of cases described in the medical literature, there is no specific curative treatment. Management is supportive and symptomatic, focusing on correction of electrolyte and metabolic abnormalities caused by the renal tubular dysfunction, skin care with emollients and keratolytics for ichthyosis, and monitoring of growth and development. A multidisciplinary approach involving nephrologists, dermatologists, and clinical geneticists is recommended.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Fanconi syndrome-ichthyosis-dysmorphism syndrome.

View clinical trials →

No actively recruiting trials found for Fanconi syndrome-ichthyosis-dysmorphism syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Fanconi syndrome-ichthyosis-dysmorphism syndrome community →

No specialists are currently listed for Fanconi syndrome-ichthyosis-dysmorphism syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Fanconi syndrome-ichthyosis-dysmorphism syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fanconi syndrome-ichthyosis-dysmorphism syndromeForum →

No community posts yet. Be the first to share your experience with Fanconi syndrome-ichthyosis-dysmorphism syndrome.

Start the conversation →

Latest news about Fanconi syndrome-ichthyosis-dysmorphism syndrome

No recent news articles for Fanconi syndrome-ichthyosis-dysmorphism syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Fanconi syndrome-ichthyosis-dysmorphism syndrome

What is Fanconi syndrome-ichthyosis-dysmorphism syndrome?

Fanconi syndrome-ichthyosis-dysmorphism syndrome, also known as Fanconi renotubular syndrome with ichthyosis and dysmorphism or sometimes referred to as Fanconi ichthyosis dysmorphism (FID) syndrome, is an extremely rare multisystem disorder characterized by the combination of renal Fanconi syndrome (a dysfunction of the proximal renal tubules), congenital ichthyosis (a skin disorder with widespread scaling), and distinctive facial dysmorphic features. The condition is present from birth and primarily affects the kidneys, skin, and craniofacial structures. The renal Fanconi syndrome component

How is Fanconi syndrome-ichthyosis-dysmorphism syndrome inherited?

Fanconi syndrome-ichthyosis-dysmorphism syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Fanconi syndrome-ichthyosis-dysmorphism syndrome typically begin?

Typical onset of Fanconi syndrome-ichthyosis-dysmorphism syndrome is neonatal. Age of onset can vary across affected individuals.